Felipe Couñago: Our study on ADC as an early prognostic marker has been accepted in ASTRO

Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a post on X:

“Our study has been accepted in American Society for Radiation Oncology: ‘ADC as an early prognostic marker in patients with ADT+ RT’.

This work will be part of Victor Duque’s doctoral thesis. Victor, great job!

Many thanks to all the people and entities that have made this research possible.”

Source: Felipe Couñago/X